Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc for securities fraud, following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, with a deadline of December 23, 2025, for investors to seek lead plaintiff status [3]. - The complaint alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in James Hardie common stock [3]. Group 2: Company Background - James Hardie is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [4]. Group 3: Allegations of Fraud - During the relevant period, James Hardie claimed strong performance in its North American fiber cement segment, asserting "inherent strength" and "underlying momentum" in its strategy [5]. - The lawsuit alleges that the reported sales were due to inventory loading by channel partners rather than genuine customer demand, indicating potential fraudulent practices [5]. Group 4: Stock Performance - On August 19, 2025, James Hardie disclosed a 12% decline in North American fiber cement sales, leading to a stock price drop of $9.79 per share, or over 34%, from $28.43 to $18.64 [6].

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. for securities fraud following a significant drop in stock price attributed to potential violations of federal securities laws [2][4]. Group 1: Lawsuit Details - The lawsuit is led by Bleichmar Fonti & Auld LLP and claims violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [4]. - Investors have until January 2, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [4]. Group 2: Financial Performance - CarMax reported disappointing financial results for Q2 of fiscal year 2026, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [7]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million in the previous year [7]. Group 3: Stock Price Impact - Following the financial results announcement on September 25, 2025, CarMax's stock price dropped by $11.45 per share, or roughly 20%, from $57.05 to $45.60 [8]. - The unexpected departure of CEO Bill Nash on November 6, 2025, and a weak preliminary Q3 outlook led to an additional stock price drop of over 24% [8]. Group 4: Company Operations - CarMax's previous claims of strong and sustainable demand for its cars were allegedly misleading, as the demand surge was primarily due to customers purchasing vehicles before the imposition of U.S. tariffs [5][6].

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. for securities fraud, following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Synopsys, Inc. specializes in design automation software products used for designing and testing integrated circuits. Its Design IP segment, which provides pre-designed silicon components, has been the fastest-growing segment, increasing from 25% of revenue in 2022 to 31% in 2024 [4]. Financial Performance - In Q3 2025, Synopsys reported a revenue of $425.9 million for its Design IP segment, reflecting a 7.7% decline year-over-year. The net income was $242.5 million, marking a 43% year-over-year decline [6]. Customer Dynamics - The lawsuit alleges that contrary to Synopsys's claims of strong customer reliance and market strength, its Design IP customers began requiring more customization, negatively impacting the economics of the Design IP business and threatening its business model [5]. Stock Market Reaction - Following the release of disappointing Q3 2025 results, Synopsys's stock price fell from $604.37 per share to $387.78 per share, a decline of nearly 36% in one day [6].

BENSALEM, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of HelloFresh SE (“HelloFresh” or the “Company”) (OTC: HELFY, HLFFF) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HELLOFRESH SE (HELFY, HLFFF), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal ri ...

LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of HelloFresh SE (“HelloFresh” or the “Company”) (OTC: HELFY, HLFFF) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON HELLOFRESH SE (HELFY, HLFFF), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On November 6, 2025, Grizzly R ...

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired Six Flags Entertainment Corporation f/k/a CopperSteel HoldCo, Inc. (“Six Flags” or the “Company”) (NYSE: FUN) common stock pursuant or traceable to the Company’s registration statement and prospectus issued in connection with the July 1, 2024 merger of legacy Six Flags Entertainment Corporation (“Legacy Six ...

Core Viewpoint - A shareholder has filed a securities class action lawsuit against DexCom, Inc. for alleged misrepresentations regarding the accuracy and functionality of its G7 continuous glucose monitoring system, affecting investors who purchased securities between January 8, 2024, and September 17, 2025 [1][3]. Group 1 - The lawsuit claims that the defendants made false statements about the reliability and enhancements of the Dexcom G7 device, as well as the company's manufacturing capabilities [3]. - Investors who acquired DexCom securities during the specified period are encouraged to consider their legal rights and options regarding the class action [2][4]. - The deadline to file as a lead plaintiff in the class action is December 26, 2025, with no fees or expenses required from shareholders [4]. Group 2 - Bernstein Liebhard LLP, the law firm handling the case, has a history of recovering over $3.5 billion for clients and has represented large public and private pension funds [5]. - The firm has been recognized multiple times for its success in litigating class actions, indicating a strong track record in this area [5].

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired: (a) Firefly Aerospace Inc. (“Firefly” or the “Company”) (NASDAQ: FLY) common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about August 7, 2025 (the “IPO” or “Offering”); and/or (b) Firefly securities between August ...

Core Viewpoint - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving StubHub Holdings, Inc. [1][2] Company Overview - StubHub operates a ticketing marketplace for live event tickets worldwide [2]. Investigation Details - The investigation focuses on whether StubHub and certain top executives made materially false and/or misleading statements and/or omitted material information regarding StubHub's business and operations [2]. About Robbins Geller - Robbins Geller is a leading law firm representing investors in securities fraud and shareholder litigation, ranked 1 in securing monetary relief for investors in four out of the last five years [3]. - In 2024, Robbins Geller recovered over $2.5 billion for investors in securities-related class action cases, more than the next five law firms combined [3]. - The firm has a history of obtaining significant securities class action recoveries, including the largest ever at $7.2 billion in the Enron case [3].

Lost Money on MoonLake Immunotherapeutics (MLTX)? Contact Levi & Korsinsky Before December 15, 2025 to Join Class ActionNovember 19, 2025 9:12 AM EST | Source: Levi & Korsinsky, LLPNew York, New York--(Newsfile Corp. - November 19, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ: MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/moonlake-lawsuit-submissio ...